Trial intelligence / Profile preview

Autologous mesenchymal progenitor stem cells vs platelet-rich growth factor plasma in arthrosis

2011-006036-23Phase 2Completed

Sponsor
Cima Universidad de Navarra
Start
Jan 2012
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Phase 2 trial of autologous mesenchymal progenitor stem cells and platelet-rich plasma in osteoarthritis (OA) (2 arms), sponsored by Cima Universidad de Navarra. Started Jan 2012; status: completed.

02

Drugs

autologous mesenchymal progenitor stem cellsplatelet-rich plasma
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on 2011-006036-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-006036-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call